- Home
- PODD vs SSNC Comparison
PODD vs SSNC Comparison
Compare PODD & SSNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- SSNC
- Stock Information
- Founded
- PODD 2000
- SSNC 1986
- Country
- PODD United States
- SSNC United States
- Employees
- PODD N/A
- SSNC N/A
- Industry
- PODD Medical/Dental Instruments
- SSNC EDP Services
- Sector
- PODD Health Care
- SSNC Technology
- Exchange
- PODD Nasdaq
- SSNC Nasdaq
- Market Cap
- PODD 22.1B
- SSNC 20.9B
- IPO Year
- PODD 2007
- SSNC 1996
- Fundamental
- Price
- PODD $344.71
- SSNC $83.00
- Analyst Decision
- PODD Strong Buy
- SSNC Strong Buy
- Analyst Count
- PODD 19
- SSNC 9
- Target Price
- PODD $356.58
- SSNC $101.11
- AVG Volume (30 Days)
- PODD 575.3K
- SSNC 1.6M
- Earning Date
- PODD 11-06-2025
- SSNC 10-23-2025
- Dividend Yield
- PODD N/A
- SSNC 1.30%
- EPS Growth
- PODD N/A
- SSNC 20.69
- EPS
- PODD 3.45
- SSNC 3.37
- Revenue
- PODD $2,521,800,000.00
- SSNC $6,148,400,000.00
- Revenue This Year
- PODD $29.32
- SSNC $8.28
- Revenue Next Year
- PODD $18.37
- SSNC $5.86
- P/E Ratio
- PODD $100.37
- SSNC $24.59
- Revenue Growth
- PODD 27.11
- SSNC 6.67
- 52 Week Low
- PODD $230.05
- SSNC $69.61
- 52 Week High
- PODD $353.50
- SSNC $91.07
- Technical
- Relative Strength Index (RSI)
- PODD 65.46
- SSNC 45.61
- Support Level
- PODD $324.97
- SSNC $80.41
- Resistance Level
- PODD $341.03
- SSNC $85.99
- Average True Range (ATR)
- PODD 12.16
- SSNC 1.71
- MACD
- PODD 2.13
- SSNC -0.20
- Stochastic Oscillator
- PODD 98.88
- SSNC 42.02
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About SSNC SS&C Technologies Holdings Inc.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.